BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 27, 2009
View Archived Issues
Rigel Takes Hit on R788 Data, But Partnering Thesis Intact
Rigel Pharmaceuticals Inc. said a midstage study of rheumatoid arthritis drug R788 missed the mark, a development that might complicate partnership talks but won't end them. (BioWorld Today)
Read More
VC Money: Biotech Finds a Cure for the Low-Cash Summer Blues
Read More
Vertex's Future Milestone Sale Creative If There's a Market
Read More
NewCo News: Intellikine Moves into Busy P13K Space with Tricks Up Its Sleeve
Read More
CytRx Bolsters Cash by $20M to Boost Lead Drug Programs
Read More
Not Satisfied with $80B, Will Obama Get More from PhRMA?
Read More
Other News To Note
Read More
Clinic Roundup
Read More